Characterisation of Occupational Allergy to Drosophila

NCT ID: NCT02535793

Last Updated: 2016-04-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Allergy is a very common problem and can be a handicap in everyday life, specially when symptoms occur at work place. Some persons working with drosophila developed respiratory symptoms. Investigators tried to analyze if these manifestations could be due to a specific allergy to drosophila.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To do so, investigators invited laboratory workers who presented any symptoms in presence of drosophila to undergo skin prick tests in order to determine if a specific sensibilization to drosophila exists. Then, a blood sample is taken from these persons to research specific IgE directed against drosophila. By this way, investigators hope determine if a specific allergy to drosophila exists, its characteristics as prevalence, symptoms, populations concerned...in order to better protect laboratory workers and prevent allergy incidence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drosophila Clinical Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

laboratory workers with symptoms in presence of drosophila

Group Type OTHER

blood test (four dry tubes 7ml) and prick tests

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood test (four dry tubes 7ml) and prick tests

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* major males or females (aged \<68) who work in laboratory with drosophila in Montpellier (France)
* clinical symptoms in presence of drosophila
* The subject must be affiliated to a social security scheme
* Provision of informed consent prior to any study specific procedures

Exclusion Criteria

* The patient has indicated against (or incompatible drug combination) concerning the implementation of a prick test
* antihistamine cure in progress
* Inability to understand the nature and goals of the study and / or communication difficulties with the investigator
* No affiliation to a French social security recipient or not such a scheme
* Major protected by law (guardianship, curator or under judicial protection)
* deprivation of liberty by judicial or administrative decision
* Increased likelihood of non compliance to the protocol or abandonment under study
* pregnancy or breastfeeding
Minimum Eligible Age

18 Years

Maximum Eligible Age

68 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Arnaud de Villeneuve

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UF 9410

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Microbiota and Allergy
NCT04750980 COMPLETED